Genetic Signatures Limited (GSS) is a molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3Base™.
The company deals in the the research and commercialisation of identifying individual genetic signatures to aid in the diagnosis of infectious diseases, and the sale of associated products into the diagnostic & research marketplaces.